WAT · 8-K · 20260804PR331413

Products and Technology

WATERS CORP /DE/ · 2026-08-04 · Importance 25 · Surprise 32

ASD instrument revenue increased 8% in constant currency, indicating continued demand for Waters’ analytical instrument portfolio. Chemistry consumables growth was in the double digits, outpacing instrument growth and supporting recurring demand across laboratory workflows. Growth was led by Pharma and A&G customers as the recovery expanded into additional customer segments. The release does not identify a specific new product launch or technology transition.

Key facts

• ASD instrument revenue for the quarter: $240 million, up 5% reported and 8% constant currency. source